Eiger BioPharmaceuticals Inc
NASDAQ:EIGR
Eiger BioPharmaceuticals Inc
Cash from Investing Activities
Eiger BioPharmaceuticals Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Eiger BioPharmaceuticals Inc
NASDAQ:EIGR
|
Cash from Investing Activities
$74.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
21%
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-76%
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is Eiger BioPharmaceuticals Inc's Cash from Investing Activities?
Cash from Investing Activities
74.2m
USD
Based on the financial report for Dec 31, 2023, Eiger BioPharmaceuticals Inc's Cash from Investing Activities amounts to 74.2m USD.
What is Eiger BioPharmaceuticals Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
21%
Over the last year, the Cash from Investing Activities growth was 671%.